A project from the American Society of Retina SpecialistsSign in to view content
Extended Efficacy and Safety of MCO-010 Optogenetic Therapy for RP: 126-Week Results From the RESTORE Follow-Up Study (REMAIN)
- Video
- Published 2025
Related
Category: Hereditary Retinal Disease & Genetics